Treatment method and product for uterine fibroids using purified collagenase
US10369110B2 · kind B2 · utility
1Cited by
6References
36Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 14, 2014 |
| Grant date | Aug 6, 2019 |
| Priority date | — |
| Expiry date | Mar 14, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y304/24003
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compositions and methods for treating uterine fibroids, wherein a uterine fibroid treatment agent comprising collagenase in an amount effective to cause shrinkage of uterine fibroids is injected or inserted into the uterine fibroid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.